Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
2014 1
2015 1
2016 1
2017 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for brain dziki
Your search for Brian Dziki retrieved no results
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Secondary end points included disability worsening confirmed at 3 months or 6 months, disability improvement confirmed at 6 months, the number of gadolinium-enhancing lesions per T1-weighted magnetic resonance imaging (MRI) scan, the annualized rate of new or enlarging lesions on …
Secondary end points included disability worsening confirmed at 3 months or 6 months, disability improvement confirmed at 6 months, the numb …
Signature changes in ubiquilin expression in the R6/2 mouse model of Huntington's disease.
Safren N, Chang L, Dziki KM, Monteiro MJ. Safren N, et al. Brain Res. 2015 Feb 9;1597:37-46. doi: 10.1016/j.brainres.2014.12.008. Epub 2014 Dec 12. Brain Res. 2015. PMID: 25511991 Free PMC article.
Here we provide a comprehensive assessment of the expression and localization of all four ubiquilin proteins in both normal and R6/2-affected mice brains, using antibodies specific for each protein. Ubiquilin-1, 2 and 4 proteins were detected throughout the brain, w …
Here we provide a comprehensive assessment of the expression and localization of all four ubiquilin proteins in both normal and R6/2-affecte …
Solubilized extracellular matrix bioscaffolds derived from diverse source tissues differentially influence macrophage phenotype.
Dziki JL, Wang DS, Pineda C, Sicari BM, Rausch T, Badylak SF. Dziki JL, et al. J Biomed Mater Res A. 2017 Jan;105(1):138-147. doi: 10.1002/jbm.a.35894. Epub 2016 Sep 21. J Biomed Mater Res A. 2017. PMID: 27601305
The results show that macrophages exposed to small intestinal submucosa (SIS), urinary bladder matrix (UBM), brain ECM (bECM), esophageal ECM (eECM), and colonic ECM (coECM) express a predominant M2-like macrophage phenotype, which is pro-remodeling and anti-inflammatory ( …
The results show that macrophages exposed to small intestinal submucosa (SIS), urinary bladder matrix (UBM), brain ECM (bECM), esopha …
Age dependency of the susceptibility of rats to aminooxyacetic acid seizures.
Turski W, Dziki M, Parada J, Kleinrok Z, Cavalheiro EA. Turski W, et al. Brain Res Dev Brain Res. 1992 Jun 19;67(2):137-44. doi: 10.1016/0165-3806(92)90214-h. Brain Res Dev Brain Res. 1992. PMID: 1511512
AOAA seizures in 14-day-old rats were blocked by clonazepam and valproate, but not by phenobarbital, carbamazepine, diphenylhydantoin, trimethadione or ethosuximide. Morphological analysis of brains from 14-day- and 3-month-old rats which experienced AOAA seizures did not …
AOAA seizures in 14-day-old rats were blocked by clonazepam and valproate, but not by phenobarbital, carbamazepine, diphenylhydantoin, trime …